🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
HIK.L
LSE
🇬🇧 UK ISA ✓
Hikma Pharmaceuticals PLC
Pharmaceuticals
42Score
DipBuster Score™
£14.16
£0.05 (-0.35%)
Live price · Source: Yahoo
52-Week Position
£11.87
24% of range
£21.46
Beta
0.643
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.643
52W High£21.46
52W Low£11.87
🤖
Watch — Score 42/100
Zone: Buy Zone
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt CapN/A
52W Position24% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.643
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for Hikma Pharmaceuticals PLC free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
30/25
Momentum & Volume
7/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
🟡
Watch
DipBuster Score: 42/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable fina…
Sector
Pharmaceuticals
Market
🇬🇧 LSE
CEO
Said Samih Taleb Darwazah
Staff
9,500 employees
Website